Related Experiment Video
Updated: Sep 9, 2025

Rapid Isolation of Dorsal Root Ganglion Macrophages
Published on: September 7, 2019
RIPK3 regulates microglial polarization through the TLR4/MyD88 pathway in neuropathic pain
Sihan E1, Qingbiao Song1, Zhaokun Zhang2
1School of Anesthesiology, Shandong Second Medical University, Weifang, China.
Abstract:
Peripheral nerve injury activates microglia in the spinal, promoting microglial polarization and facilitating neuropathic pain progression. Necroptosis, a form of cell death, plays a crucial role in various neurological diseases and receptor-interacting protein kinases 3(RIPK3) a key molecular in the process. This study investigates to explore that RIPK3 regulates microglial polarization through the TLR4/MyD88 signaling pathway in neuropathic pain. By using a chronic constriction injury (CCI) model in mice, we found that peripheral nerve injury promoted M1 polarization and activated the TLR4/MyD88 pathway in spinal cord; in BV-2 microglia models, TNF-α/Z-VAD co-induction triggered M1 polarization through TLR4/MyD88 pathway, TLR4 antagonists suppressed these effects both in vivo and in vitro. Administration of GSK'872 (RIPK3 inhibitor) inhibited TLR4/MyD88 pathway, reduced microglial M1 polarization, promoted microglial M2 polarization and alleviated CCI-induced hyperalgesia. These findings suggest that necroptosis is a key cellular mechanism in peripheral injury-induced neuropathic pain and that RIPK3 regulates microglial polarization via the TLR4/MyD88 pathway, providing a new target for neuropathic pain treatment and clinical prevention.
Insights
Receptor-interacting protein kinase 3 (RIPK3) drives neuropathic pain by promoting M1 microglial polarization via the TLR4/MyD88 pathway. Inhibiting RIPK3 alleviates pain and shifts polarization to M2, offering a new therapeutic target.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Peripheral nerve injury triggers microglial activation and polarization in the spinal cord, contributing to neuropathic pain.
- Necroptosis, a regulated form of cell death involving receptor-interacting protein kinases 3 (RIPK3), is implicated in neurological disorders.
Purpose of the Study:
- To investigate the role of RIPK3 in regulating microglial polarization through the Toll-like receptor 4 (TLR4)/Myeloid differentiation primary response 88 (MyD88) signaling pathway in the context of neuropathic pain.
Main Methods:
- A chronic constriction injury (CCI) mouse model was used to induce neuropathic pain.
- In vitro studies utilized BV-2 microglia models treated with tumor necrosis factor-alpha (TNF-α)/Z-VAD.
- RIPK3 inhibition was achieved using GSK'872, and TLR4 antagonism was employed.
Main Results:
- CCI induced M1 microglial polarization and activated the TLR4/MyD88 pathway in the spinal cord.
- TNF-α/Z-VAD treatment promoted M1 polarization via TLR4/MyD88 in microglia, an effect blocked by TLR4 antagonists.
- GSK'872 administration inhibited the TLR4/MyD88 pathway, reduced M1 polarization, enhanced M2 polarization, and alleviated CCI-induced hyperalgesia.
Conclusions:
- Necroptosis, mediated by RIPK3, is a critical cellular mechanism in peripheral nerve injury-induced neuropathic pain.
- RIPK3 regulates microglial polarization through the TLR4/MyD88 signaling pathway.
- Targeting RIPK3 offers a potential therapeutic strategy for neuropathic pain treatment and prevention.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Analgesia and Pain Management
Nociception

